POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized, multi-center, active-controlled parallel-comparison of
POLAT-001 to latanoprost ophthalmic solution in patients with ocular hypertension and primary
open-angle glaucoma.